FDA panel endorses lower-dose Moderna COVID shot for booster
FDA grapples with timing of booster for J&J COVID-19 vaccine.
69 across the spectrum. Choose a side on the bar to jump to it.
National story. 291 articles from 71 sources. 69 are on the bar; 2 are international, entertainment or tech outlets, listed separately. Updated Oct 15, 2021.
Left
21 sourcesCenter
40 sourcesFDA advisers to weigh in on COVID-19 booster shots for Johnson & Johnson vaccine recipients
Right
8 sourcesFDA panel endorses Moderna’s COVID-19 booster vaccine for certain high risk groups
Other outlets
International, entertainment and tech outlets, by their rating. Not counted in the bar above. How we count coverage
Left
3 articlesFDA panel backs half-dose Moderna booster for older and at-risk US adults
Center
0 articlesNone
Right
0 articlesNone
The story so far
3 developments- Oct 13, 2021FDA grapples with timing of booster for J&J COVID-19 vaccine
- Oct 14, 2021FDA panel endorses lower-dose Moderna COVID shot for booster
- Oct 15, 2021FDA panel endorses booster shot for J&J COVID-19 vaccine
Who covered each development
No new developments
Quiet for 1833 daysLast development · Oct 15, 2021 — FDA panel endorses booster shot for J&J COVID-19 vaccine